G8583 Beta‑blocker Contraindicated HCPCS Reimbursement

HCPCS Level II code G8583 identifies cases where a beta-blocker is clinically contraindicated. Nationally, clear documentation of medication contraindications affects quality reporting, medication safety metrics, and appropriate care pathways for patients with conditions that make beta-blocker therapy unsafe. The code supports accurate clinical records and can influence quality measure exceptions.

Key payers in the national discussion include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find contextual information on clinical use and documentation of G8583, expected sites of service, and how this code fits into medication safety and quality measurement frameworks. The publication summarizes common clinical scenarios that might prompt use of the code and outlines what is and is not available in the source input.

The report provides benchmarks and policy-relevant notes where available, clarifies documentation expectations tied to the code, and highlights areas where data were not provided in the input. This summary is intended for administrators, clinical coders, quality officers, and policy analysts seeking concise guidance on the role of G8583 in national billing and quality reporting practices.

Billing Code Overview

HCPCS Level II code G8583 denotes Beta-blocker contraindicated. This code is used to document that a patient has a clinical contraindication to beta-blocker therapy and to record that beta-blockers are not appropriate for the patient’s care plan.

Service type: Documentation of medication contraindication and clinical decision-making
Typical site of service: Outpatient clinic, inpatient hospital, emergency department, or other settings where medication decisions are made

Clinical Context

A typical patient scenario involves an adult patient with a history of ischemic heart disease or heart failure for whom a beta-blocker would normally be indicated but is contraindicated due to documented clinical factors. For example, a 68-year-old male with symptomatic bradycardia (resting heart rate 40 bpm), symptomatic hypotension, or a history of severe reactive airway disease (status asthmaticus) presents to the cardiology clinic after hospital discharge following an acute coronary syndrome. The outpatient clinician documents that beta-blocker therapy is contraindicated and records the reason in the medical record.

Clinical workflow: The clinician evaluates current vitals, review of systems, medication list, and prior hospital notes. If beta-blocker therapy is contraindicated, the clinician documents the contraindication in the encounter note, assigns the appropriate HCPCS Level II code G8583 on the claim form, selects relevant ICD-10 diagnosis codes for the underlying cardiovascular condition, and applies any appropriate modifiers based on billing rules before submission to payors such as Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, BUCA, and Medicare.

Coding Specifications

Modifier	Description	When to Use
`24`	Unrelated Evaluation and Management service by the same physician during a postoperative period	Use when an unrelated E/M is provided during a global period and documentation supports unrelated problem management.

Taxonomy Code	Specialty	Notes
`207RC0000X`	Cardiology	Cardiologists commonly assess beta-blocker candidacy and document contraindications.
`207RH0002X`	Interventional Cardiology	Interventional cardiologists manage acute coronary syndromes and may document contraindications post-procedure.
`163WL0500X`	Internal Medicine	Hospitalists and internists manage comorbid conditions and document medication contraindications.
`207RI0200X`	Cardiac Electrophysiology	Electrophysiologists evaluate bradyarrhythmias and contraindications to beta-blockers.
`207R00000X`	Family Medicine	Primary care physicians document chronic disease management decisions including medication contraindications.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`I49.5`	Sick sinus syndrome	Sinus node dysfunction often causes symptomatic bradycardia, a contraindication to beta-blockers.
`R00.1`	Bradycardia, unspecified	Documented bradycardia can contraindicate initiation or continuation of beta-blocker therapy.
`J44.1`	Chronic obstructive pulmonary disease with (acute) exacerbation	Severe reactive airway disease or COPD exacerbation increases risk with beta-blockers, especially nonselective agents.
`I50.9`	Heart failure, unspecified	Decompensated heart failure or hypotension related to heart failure may contraindicate beta-blocker use until stabilized.
`I95.1`	Orthostatic hypotension	Significant hypotension is a clinical reason to avoid beta-blockers.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`93000`	Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report	Used before deciding on beta-blocker therapy when evaluating bradycardia or ischemia.
`93010`	Electrocardiogram interpretation only	Interpretation billed when ECG was performed by another provider; helps document rhythm concerns that contraindicate beta-blockers.
`99213`	Office or other outpatient visit for the evaluation and management of an established patient, typically 15 minutes	Common E/M level for documenting contraindication and medication management.
`99214`	Office or other outpatient visit for the evaluation and management of an established patient, typically 25 minutes	Used for more complex visits requiring detailed documentation of contraindication and comorbidity review.
`93306`	Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode, when performed; complete	Performed to evaluate cardiac function when considering beta-blocker risks in heart failure or cardiomyopathy.
`93279`	External cardiac monitor report, physician review and interpretation only	Used when ambulatory monitoring reveals bradyarrhythmia supporting documentation that beta-blocker therapy is contraindicated.

OpenPayer

Summary & Overview

HCPCS G8583: Beta-blocker Contraindicated